|
|||||
|
|
Prasugrel vs. clopidogrel in acute coronary syndrome patients treated with prasugrel |
|
| Authors: | W. H. Olson PhD Y.‐W. Ma PhD F. Laliberté MA P. Lefebvre MA C. Crivera PharmD MPH J. R. Schein DrPH MPH L. E. Fields MD K. Dea MA G. Germain MA S. M. Lynch PhD |
| Affiliation: | 1. Janssen Scientific Affairs, LLC, , Raritan, NJ, USA;2. Johnson & Johnson Consumer Companies Inc., , Horsham, PA, USA;3. Groupe d'analyse, Ltée, , Montréal, QC, Canada;4. Janssen Pharmaceuticals Inc., , Raritan, NJ, USA;5. Department of Sociology, Duke University, , Durham, NC, USA |
| Abstract: | |
| Keywords: | acute coronary syndrome antiplatelet agent Bayesian data analysis clopidogrel prasugrel |